🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will see how PF-05212377, an experimental drug to treat symptoms...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2013-11
Trial ID
NCT02005991
Treatments Being Tested
This study will assess the safety and tolerability of ascending single oral...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-09
Trial ID
NCT00948662
Treatments Being Tested
The purpose of this study is to evaluate the relationship between plasma dr...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-12
Trial ID
NCT01258751
Treatments Being Tested
This is a multiple ascending dose study to assess the safety, tolerability ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-07
Trial ID
NCT01159496
Treatments Being Tested
It is hypothesized that PF-05212377 (SAM-760) will reverse scopolamine indu...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-04
Trial ID
NCT01213355
This study will evaluate safety and efficacy of PF-05212377 in subjects wit...
Status
Terminated
Location
ATP Clinical Research, Inc
Start Date
2012-11
Trial ID
NCT01712074
Treatments Being Tested